Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Eli Lilly (LLY) Stock Just Reached a New All-Time High

By Josh Enomoto, InvestorPlace Contributor

Pharma giant Eli Lilly saw LLY stock reach record heights as the company posted strong Q2 results, undergirded by a key diabetes drug.

PTRA Stock Alert: Proterra Files for Ch. 11 Bankruptcy

By Josh Enomoto, InvestorPlace Contributor

Although Proterra attempted to electrify the heavy-duty vehicle sector, the implosion of PTRA stock imposed a rude awakening.

Investing in AI on a Budget: 3 Undervalued Stocks You Can’t Ignore

By Josh Enomoto, InvestorPlace Contributor

While digital intelligence may be the hot ticket in town, you don’t have to pay an arm and a leg with these budget AI investing ideas.

3 Biotech Stocks That Analysts Are Drooling Over

By Josh Enomoto, InvestorPlace Contributor

With the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time.

A Bargain Hunter’s Dream: 7 Must-Own Stocks Under $20

By Josh Enomoto, InvestorPlace Contributor

Although myriad enterprises have shot through the roof, investors seeking must-own stocks under $20 have their fair share of ideas.

Load More